Gelareh Farshid

Summary

Affiliation: South Australia
Country: Australia

Publications

  1. ncbi request reprint Mucocele-like lesions of the breast: a benign cause for indeterminate or suspicious mammographic microcalcifications
    Gelareh Farshid
    BreastScreen SA, Adelaide, Australia
    Breast J 11:15-22. 2005
  2. ncbi request reprint Combined use of imaging and cytologic grading schemes for screen-detected breast abnormalities improves overall diagnostic accuracy
    Gelareh Farshid
    BreastScreen SA, Wayville, South Australia
    Cancer 105:282-8. 2005
  3. ncbi request reprint The use of fine-needle aspiration cytology and core biopsy in the assessment of highly suspicious mammographic microcalcifications: analysis of outcome for 182 lesions detected in the setting of a population-based breast cancer screening program
    Gelareh Farshid
    BreastScreen South Australia, Wayville, Australia
    Cancer 99:357-64. 2003
  4. ncbi request reprint Atypical presentations of screen-detected DCIS Implications for pre-operative assessment and surgical intervention
    Gelareh Farshid
    BreastScreen SA and Division of Tissue Pathology, Institute of Medical and Veterinary Science, Frome Road, Adelaide 5000, South Australia
    Breast 16:161-71. 2007
  5. ncbi request reprint A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node
    Gelareh Farshid
    Division of Tissue Pathology, Institute of Medical and Veterinary Science, Level 5, Frome Road, Adelaide 5000, South Australia
    Breast 13:494-501. 2004
  6. ncbi request reprint Assessment of 142 stellate lesions with imaging features suggestive of radial scar discovered during population-based screening for breast cancer
    Gelareh Farshid
    BreastScreen SA, Division of Tissue Pathology, Institute of Medical and Veterinary Science, Adelaide, South Australia
    Am J Surg Pathol 28:1626-31. 2004
  7. ncbi request reprint Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing
    Gelareh Farshid
    Division of Tissue Pathology, Institute of Medical and Veterinary Science, Adelaide, South Australia
    Am J Surg Pathol 30:1357-66. 2006
  8. doi request reprint Establishment of the Australian in situ hybridization program for the assessment of HER2 amplification in breast cancer: a model for the introduction of new biomarkers into clinical practice
    Gelareh Farshid
    Division of Surgical Pathology and Cytopathology, SA Pathology, Adelaide, SA, Australia
    Diagn Mol Pathol 19:187-93. 2010
  9. pmc An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
    Philip A Gregory
    Division of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, SA 5000, Australia
    Mol Biol Cell 22:1686-98. 2011
  10. doi request reprint Predictors of malignancy in screen-detected breast masses with indeterminate/equivocal (grade 3) imaging features
    Gelareh Farshid
    Pathology, BreastScreen SA, 1 Goodwood Road, Wayville, SA 5065, Australia
    Breast 20:56-61. 2011

Detail Information

Publications20

  1. ncbi request reprint Mucocele-like lesions of the breast: a benign cause for indeterminate or suspicious mammographic microcalcifications
    Gelareh Farshid
    BreastScreen SA, Adelaide, Australia
    Breast J 11:15-22. 2005
    ..Correlating the cytomorphology of mucinous lesions of the breast with their mammographic appearance may permit more precise preoperative diagnosis...
  2. ncbi request reprint Combined use of imaging and cytologic grading schemes for screen-detected breast abnormalities improves overall diagnostic accuracy
    Gelareh Farshid
    BreastScreen SA, Wayville, South Australia
    Cancer 105:282-8. 2005
    ..The impact of integrating lesion grades from both disciplines on the accuracy of assessment of screen-detected lesions has not been investigated...
  3. ncbi request reprint The use of fine-needle aspiration cytology and core biopsy in the assessment of highly suspicious mammographic microcalcifications: analysis of outcome for 182 lesions detected in the setting of a population-based breast cancer screening program
    Gelareh Farshid
    BreastScreen South Australia, Wayville, Australia
    Cancer 99:357-64. 2003
    ..Core biopsy is used if FNAB is not diagnostic. In the context of increased use of core biopsy at other centers, the authors reviewed their experience with the cytologic assessment of highly suspicious microcalcifications...
  4. ncbi request reprint Atypical presentations of screen-detected DCIS Implications for pre-operative assessment and surgical intervention
    Gelareh Farshid
    BreastScreen SA and Division of Tissue Pathology, Institute of Medical and Veterinary Science, Frome Road, Adelaide 5000, South Australia
    Breast 16:161-71. 2007
    ..4% of cases. One in five cases of DCIS detected during mammographic screening has features other than pure microcalcifications. This has implications for pre-operative assessment and surgical management...
  5. ncbi request reprint A decision aid for predicting non-sentinel node involvement in women with breast cancer and at least one positive sentinel node
    Gelareh Farshid
    Division of Tissue Pathology, Institute of Medical and Veterinary Science, Level 5, Frome Road, Adelaide 5000, South Australia
    Breast 13:494-501. 2004
    ..Approximately 50-70% of patients with positive SN have no further nodal involvement. Estimates of the risk of non-sentinel node (NSN) involvement would aid decisions regarding further axillary surgery...
  6. ncbi request reprint Assessment of 142 stellate lesions with imaging features suggestive of radial scar discovered during population-based screening for breast cancer
    Gelareh Farshid
    BreastScreen SA, Division of Tissue Pathology, Institute of Medical and Veterinary Science, Adelaide, South Australia
    Am J Surg Pathol 28:1626-31. 2004
    ..The policy of mammographic surveillance for lesions with nonmalignant core biopsies remains controversial because of the paucity of data. Ongoing evaluation is needed as more experience is reported...
  7. ncbi request reprint Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing
    Gelareh Farshid
    Division of Tissue Pathology, Institute of Medical and Veterinary Science, Adelaide, South Australia
    Am J Surg Pathol 30:1357-66. 2006
    ..Certain morphologic and immunohistochemical features are overrepresented in BRCA1-associated breast cancers but these differences have not been incorporated into the current selection criteria for genetic testing...
  8. doi request reprint Establishment of the Australian in situ hybridization program for the assessment of HER2 amplification in breast cancer: a model for the introduction of new biomarkers into clinical practice
    Gelareh Farshid
    Division of Surgical Pathology and Cytopathology, SA Pathology, Adelaide, SA, Australia
    Diagn Mol Pathol 19:187-93. 2010
    ....
  9. pmc An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition
    Philip A Gregory
    Division of Human Immunology, Centre for Cancer Biology, SA Pathology, Adelaide, SA 5000, Australia
    Mol Biol Cell 22:1686-98. 2011
    ....
  10. doi request reprint Predictors of malignancy in screen-detected breast masses with indeterminate/equivocal (grade 3) imaging features
    Gelareh Farshid
    Pathology, BreastScreen SA, 1 Goodwood Road, Wayville, SA 5065, Australia
    Breast 20:56-61. 2011
    ..We wished to determine the predictors of malignancy for these common lesions, so as to reduce surgery for benign lesions...
  11. ncbi request reprint Implication of intraoperative sentinel node imprint cytology for consent in the SNAC Trial
    Melissa A Bochner
    Breast Endocrine and Surgical Oncology Unit, Royal Adelaide Hospital, Department of Surgery, University of Adelaide, Adelaide, South Australia, Australia
    ANZ J Surg 74:105-7. 2004
    ..The aim of the present study was to determine the likelihood of immediate and delayed axillary clearance in patients in the trial when nodes were subjected to intraoperative imprint cytology...
  12. ncbi request reprint Core imprint cytology of screen-detected breast lesions is predictive of the histologic results
    Gelareh Farshid
    BreastScreen SA, Wayville, South Australia, Australia
    Cancer 108:150-6. 2006
    ..If core imprint cytology (CIC) of breast cores can be shown to be reliable in a significant proportion of screen-detected lesions, this technique may be of clinical value in such clinics...
  13. doi request reprint Do breast cancer risk factors differ among those who do and do not undertake mammography screening?
    Kerri R Beckmann
    School of Population Health, University of Adelaide, Adelaide, Australia
    J Med Screen 20:208-19. 2013
    ..This study compares the breast cancer risk profiles of participants and non-participants of population-based mammography screening. Risk profiles are also compared between those who have and have not used private screening services...
  14. ncbi request reprint Intraoperative imprint cytologic assessment of the sentinel node for early breast cancer
    Melissa A Bochner
    Breast Endocrine and Surgical Oncology Unit, Royal Adelaide Hospital, North Terrace, Adelaide, 5000, South Australia, Australia
    World J Surg 27:430-2. 2003
    ..With the use of this technique, more than 50% of lymph node-positive patients would potentially be spared a second operation...
  15. doi request reprint Impact of hormone replacement therapy use on mammographic screening outcomes
    Kerri R Beckmann
    School of Population Health, University of Adelaide, Adelaide, SA, Australia
    Cancer Causes Control 24:1417-26. 2013
    ....
  16. ncbi request reprint 99mTc-Evans blue dye for mapping contiguous lymph node sequences and discriminating the sentinel lymph node in an ovine model
    Chris Tsopelas
    Nuclear Medicine Department, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, 5000, Australia
    Ann Surg Oncol 13:692-700. 2006
    ..Previous studies in smaller animal models suggested that this agent could have advantages over the dual-injection technique of radiocolloid/blue dye...
  17. doi request reprint Validation of the multiplex ligation-dependent probe amplification (MLPA) technique for the determination of HER2 gene amplification in breast cancer
    Gelareh Farshid
    Royal Adelaide Hospital Campus, SA Pathology, BreastScreen, SA
    Diagn Mol Pathol 20:11-7. 2011
    ..Multiplex ligation-dependent probe amplification (MLPA) is a polymerase chain reaction-based assay that can assess HER2 gene copy number relative to control genes...
  18. doi request reprint The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
    Philip A Gregory
    Hanson Institute and Division of Human Immunology, Institute of Medical and Veterinary Science, Adelaide, SA 5000, Australia
    Nat Cell Biol 10:593-601. 2008
    ..Expression of the miR-200 family was also lost in regions of metaplastic breast cancer specimens lacking E-cadherin. These data suggest that downregulation of the microRNAs may be an important step in tumour progression...
  19. ncbi request reprint Leiomyosarcoma of somatic soft tissues: a tumor of vascular origin with multivariate analysis of outcome in 42 cases
    Gelareh Farshid
    Division of Tissue Pathology, Institute of Medical and Veterinary Science, University of Adelaide, South Australia, Australia
    Am J Surg Pathol 26:14-24. 2002
    ..Nevertheless, in view of their vascular origin, the possibility that tumor disruption may facilitate or promote access to the bloodstream merits further study...
  20. ncbi request reprint The tissue distribution of Evans blue dye in a sheep model of sentinel node biopsy
    Michael Green
    Royal Hampshire County Hospital, Winchester, UK
    Nucl Med Commun 27:695-700. 2006
    ..Tc-Evans blue is a 'single dose' agent for lymphatic mapping combining radioactivity and blue dye for sentinel node identification. The mechanism and distribution of blue dye retention in the lymph node is not clearly understood...